Clinical Trial Update: Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 preoperative trial evaluating sorafenib in combination with cisplatin followed by paclitaxel for early-stage breast cancer has been terminated, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Emory University | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-07-28